12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
12 health care stocks experienced significant movements in Tuesday's pre-market session. Notable gainers include Sonoma Pharmaceuticals (SNOA), Qualigen Therapeutics (QLGN), and Mustang Bio (MBIO). Significant losers include DermTech (DMTK), Biolase (BIOL), and Zentalis Pharma (ZNTL).
June 18, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biolase stock dropped by 42.0% to $0.09.
The significant drop in stock price suggests a major negative event or sentiment, though specific details are not provided.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
DermTech shares fell by 50.4% to $0.17.
The sharp decline in stock price indicates a significant negative event or sentiment, though specific details are not provided.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Zentalis Pharma shares decreased by 28.61% to $5.99.
The significant drop in stock price suggests a major negative event or sentiment, though specific details are not provided.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Mustang Bio shares increased by 30.66% to $0.98.
The stock's significant rise suggests positive market sentiment, though specific catalysts are not mentioned.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Qualigen Therapeutics' stock rose by 31.57% to $0.23.
The stock's significant rise suggests positive market sentiment, though specific catalysts are not mentioned.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Sonoma Pharmaceuticals' stock surged by 63.8% to $0.28 following the release of its Q4 earnings report.
The significant increase in stock price is directly tied to the positive reception of the Q4 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100